Sort
10,766 grants matching “checkpoint inhibitor”
Biostatistics and Data Management
$280,533Haesook Kim · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Small Molecule Inhibitors of the BCL6 Oncoprotein
$280,492Arie Zask · Daysai Biopharmaceuticals, Inc. · R43 · FY2013 · CA
Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer
$280,372John Kyung Lee · Fred Hutchinson Cancer Center · P50 · FY2024 · CA
Mechanisms that coordinate cell size with mitotic entry
$280,362James B Moseley · Dartmouth College · R01 · FY2012 · GM
Project 1
$280,289Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2024 · CA
Intestinal Cell Growth Control: Role of Tyrosine Kinases
$279,995Christine Ann Cartwright · Stanford University · R01 · FY2011 · DK
Targeted Therapy for Endometrial Cancer
$279,805Kimberly K Leslie · University Of New Mexico Health Scis Ctr · R01 · FY2022 · CA
Regulation of Replication Checkpoint by Proteolysis
$279,402Hui Zhang · Yale University · R01 · FY2006 · CA
BUBR1 in the Spindle Checkpoint and Tumor Suppression
$279,353New York Medical College · R01 · FY2003 · CA
BUBR1 in the Spindle Checkpoint and Tumor Suppression
$279,353New York Medical College · R01 · FY2002 · CA
PDX tumor-TME acquired resistance
$279,123Jack Roth · University Of California, San Francisco · U54 · FY2024 · CA
Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy
$279,077Jeffrey J. Ishizuka · Yale University · K08 · FY2020 · CA
Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy
$279,077Jeffrey J. Ishizuka · Yale University · K08 · FY2022 · CA
Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy
$279,077Jeffrey J. Ishizuka · Yale University · K08 · FY2021 · CA
Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy
$279,077Jeffrey J. Ishizuka · Yale University · K08 · FY2023 · CA
BUBR1 in the Spindle Checkpoint and Tumor Suppression
$279,048New York Medical College · R01 · FY2004 · CA
pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics
$278,966Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2010 · CA
Identifying Inhibitors of the APC/C Using Yeast Mutants
$278,774University Of Virginia Charlottesville · R01 · FY2005 · CA
Identifying Inhibitors of the APC/C Using Yeast Mutants
$278,774University Of Virginia Charlottesville · R01 · FY2004 · CA
Signaling Complexes and the 14-3-3 Protein in Candida
$278,648Joy E Sturtevant · Lsu Health Sciences Center · R01 · FY2008 · AI
Mechanism of HTLV-1 Leukemogenesis
$278,616Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2002 · CA
Mechanism of HTLV-1 Leukemogenesis
$278,616Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2004 · CA
Mechanism of HTLV-1 Leukemogenesis
$278,616Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2005 · CA
Mechanism of HTLV-1 Leukemogenesis
$278,616Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2003 · CA
An Exploratory Study of UCN-01 and Irinotecan in Advanced Triple Negative Breast
$278,385Paula M Fracasso · University Of Virginia · R21 · FY2007 · CA